Gov. Bev Perdue announced today that Novartis Vaccines and Diagnostics, Inc., a global leader in vaccine and diagnostics, will add a development lab and pilot plant at the site of its pandemic and seasonal flu production facility in Holly Springs.
The company plans to create 100 new positions in North Carolina and will invest $36 million as part of the project, which was made possible in part by state grants from the Job Development Investment Grant program and One North Carolina Fund.
FRAUD ALERT
Be aware of multiple fraudulent text scams requesting payment for NCDMV fees, fines or tolls. NCDMV will NEVER request payment by text. Please report it as spam and delete. Learn More